{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:29:24Z","timestamp":1794738564575,"version":"4.9.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tstp20221158"],"award-info":[{"award-number":["tstp20221158"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312338"],"award-info":[{"award-number":["tsqn202312338"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172647"],"award-info":[{"award-number":["82172647"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073200"],"award-info":[{"award-number":["82073200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.metabol.2025.156304","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:00:09Z","timestamp":1748001609000},"page":"156304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response"],"prefix":"10.1016","volume":"170","author":[{"given":"Guo-Qiang","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan-Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Ru","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2025.156304_bb0005","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2025.156304_bb0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoural and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2025.156304_bb0015","article-title":"Neoadjuvant PD-1 blockade in resectable lung cancer","volume":"379","author":"Yang","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2025.156304_bb0020","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/cncr.33033","article-title":"Nivolumab versus everolimus in patients with advanced renal cell carcinoma: updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial","volume":"126","author":"Motzer","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.metabol.2025.156304_bb0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2025.156304_bb0030","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1200\/JCO.20.00808","article-title":"Phase Ib study of lenvatinib plus pembrolizumab in patients with unresectable hepatocellular carcinoma","volume":"38","author":"Finn","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2025.156304_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007366","article-title":"Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial","volume":"11","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.metabol.2025.156304_bb0040","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2025.156304_bb0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2025.156304_bb0050","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumour suppression, tumour microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2025.156304_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216935","article-title":"CRISPR\/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma","volume":"593","author":"Yao","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.metabol.2025.156304_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41590-024-02047-w","article-title":"The epitranscriptional factor PCIF1 orchestrates CD8(+) T cell ferroptosis and activation to control antitumour immunity","volume":"26","author":"Xiang","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2025.156304_bb0065","first-page":"1602","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2025.156304_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumour microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.metabol.2025.156304_bb0075","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2025.156304_bb0080","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.molcel.2021.08.031","article-title":"Moonlighting functions of metabolic enzymes and metabolites in cancer","volume":"81","author":"Pan","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2025.156304_bb0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.metabol.2025.156304_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"20","key":"10.1016\/j.metabol.2025.156304_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf2229","article-title":"The SAM domain-containing protein 1 (SAMD1) acts as a repressive chromatin regulator at unmethylated CpG islands","volume":"7","author":"Stielow","year":"2021","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.metabol.2025.156304_bb0100","article-title":"The CpG island-binding protein SAMD1 contributes to an unfavorable gene signature in HepG2 hepatocellular carcinoma cells","volume":"11","author":"Simon","year":"2022","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.metabol.2025.156304_bb0105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/hep.31076","article-title":"TMPRSS4 drives angiogenesis in hepatocellular carcinoma by promoting HB-EGF expression and proteolytic cleavage","volume":"72","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2025.156304_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.metabol.2025.156304_bb0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-017-02733-4","article-title":"Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin","volume":"9","author":"DeWaal","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156304_bb0120","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumour progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2025.156304_bb0125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/j.gastro.2024.05.005","article-title":"Emerging trends in gastrointestinal cancer targeted therapies: harnessing tumour microenvironment, immune factors, and metabolomics insights","volume":"167","author":"Rauth","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2025.156304_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41420-023-01463-5","article-title":"Drug-induced lactate confers ferroptosis resistance via p38-SGK1-NEDD4L-dependent upregulation of GPX4 in NSCLC cells","volume":"9","author":"Cheng","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2025.156304_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150709","article-title":"Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis","volume":"733","author":"Shen","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2025.156304_bb0140","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1038\/s41467-018-07394-5","article-title":"NUAK2 is a critical YAP target in liver cancer","volume":"9","author":"Yuan","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156304_bb0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41467-017-00906-9","article-title":"Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumourigenesis","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2025.156304_bb0150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.onc.1210669","article-title":"The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation","volume":"27","author":"Veeck","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2025.156304_bb0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41419-021-03707-7","article-title":"ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2025.156304_bb0160","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumour glycolysis, an essential sweet tooth of tumour cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.metabol.2025.156304_bb0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jconrel.2024.05.001","article-title":"An ultrasound-activated nanoplatform remodels tumour microenvironment through diverse cell death induction for improved immunotherapy","volume":"370","author":"Ma","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.metabol.2025.156304_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2019.01.001","article-title":"Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo","volume":"197","author":"Jiang","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.metabol.2025.156304_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204585","article-title":"Herpesvirus-mimicking DNAzyme-loaded nanoparticles as a mitochondrial DNA stress inducer to activate innate immunity for tumour therapy","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.metabol.2025.156304_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-024-03083-2","article-title":"Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis","volume":"23","author":"Zhao","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.metabol.2025.156304_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102179","article-title":"Res@ZIF-90 suppress gastric cancer progression by disturbing mitochondrial homeostasis","volume":"51","author":"Qiu","year":"2025","journal-title":"Transl Oncol"},{"key":"10.1016\/j.metabol.2025.156304_bb0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2024.01.014","article-title":"Hydrogel-encapsulated medium chain lipid-modified zeolite imidazole framework-90 as a promising platform for oral delivery of proteins","volume":"367","author":"Ji","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.metabol.2025.156304_bb0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2025.156304_bb0200","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.immuni.2024.08.005","article-title":"Autoantigen-specific CD4(+) T cells acquire an exhausted phenotype and persist in human antigen-specific autoimmune diseases","volume":"57","author":"Saggau","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2025.156304_bb0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2025.156304_bb0210","first-page":"4404","article-title":"Increased populations of regulatory T cells in peripheral blood and tumour-infiltrating lymphocytes in patients with gastric and esophageal cancers","volume":"9","author":"Ichihara","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.metabol.2025.156304_bb0215","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.metabol.2025.156304_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12943-017-0610-2","article-title":"ITIH5 mediates epigenetic reprogramming of breast cancer cells","volume":"16","author":"Rose","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.metabol.2025.156304_bb0225","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4161\/epi.32089","article-title":"Epigenetic inactivation of the novel candidate tumour suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotype","volume":"9","author":"Kloten","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.metabol.2025.156304_bb0230","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/carcin\/bgt375","article-title":"Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours","volume":"35","author":"Rose","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2025.156304_bb0235","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/bcr3375","article-title":"Promoter hypermethylation of the tumour-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening","volume":"15","author":"Kloten","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.metabol.2025.156304_bb0240","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13148-011-0043-5","article-title":"Aberrant DNA hypermethylation of the ITIH5 tumour suppressor gene in acute myeloid leukemia","volume":"2","author":"Oing","year":"2011","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.metabol.2025.156304_bb0245","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41421-022-00406-1","article-title":"PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation","volume":"8","author":"Chen","year":"2022","journal-title":"Cell Discov"},{"key":"10.1016\/j.metabol.2025.156304_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167508","article-title":"NUAKs promote mTOR\/c-Myc-induced glucose and glutamine reprogramming for cell growth and metastasis in breast cancer cells","volume":"1871","author":"Worral Wilfred Raj","year":"2025","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.metabol.2025.156304_bb0255","article-title":"The NF-\u03baB\/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2\/3","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.metabol.2025.156304_bb0260","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1038\/s41467-018-05939-2","article-title":"A feed forward loop enforces YAP\/TAZ signaling during tumourigenesis","volume":"9","author":"Gill","year":"2018","journal-title":"Nat Commun"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525001738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049525001738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:47:09Z","timestamp":1778564829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049525001738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"alternative-id":["S0026049525001738"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156304","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2025.156304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156304"}}